1217706-31-4
Chemical Structure
Rivastigmine metabolite-d6
Synonym(s): NAP 226-90-d6
- CAS No.: 1217706-31-4
- Formula:C10H9D6NO
- Molecular Weight:171.27
IUPAC Name: (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((6-(trifluoromethoxy)benzo[d]thiazol-2-yl-4,5,7-d3)amino)tetrahydro-2H-pyran-2-carboxylic acid
InChIKey: GQZXRLWUYONVCP-MXUURUABSA-N
SMILES: C[C@@H](C1=CC(O)=CC=C1)N(C([2H])([2H])[2H])C([2H])([2H])[2H]
Biological Activity: Rivastigmine metabolite-d6 (NAP 226-90-d6) is a deuterated form of Rivastigmine metabolite. Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368). Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rivastigmine metabolite-d6 | Rivastigmine metabolite-d6 (NAP 226-90-d6) is a deuterated form of Rivastigmine metabolite. Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368). Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rivastigmine metabolite (Standard) | ≥98% | Rivastigmine metabolite (Standard) is the analytical standard of Rivastigmine metabolite. This product is intended for research and analytical applications. Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368). Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rivastigmine metabolite | 99.01% | Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368). Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
